459 related articles for article (PubMed ID: 25993178)
1. Current and future care of patients with the cancer anorexia-cachexia syndrome.
Del Fabbro E
Am Soc Clin Oncol Educ Book; 2015; ():e229-37. PubMed ID: 25993178
[TBL] [Abstract][Full Text] [Related]
2. Cancer anorexia - cachexia syndrome.
Muliawati Y; Haroen H; Rotty LW
Acta Med Indones; 2012 Apr; 44(2):154-62. PubMed ID: 22745148
[TBL] [Abstract][Full Text] [Related]
3. Current pharmacotherapy options for cancer anorexia and cachexia.
Macciò A; Madeddu C; Mantovani G
Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481
[TBL] [Abstract][Full Text] [Related]
4. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
Graf SA; Garcia JM
Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
[TBL] [Abstract][Full Text] [Related]
5. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
6. Cachexia and anorexia: cancer's covert killer.
Davis MP; Dickerson D
Support Care Cancer; 2000 May; 8(3):180-7. PubMed ID: 10789957
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
Currow DC; Skipworth RJ
Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
[TBL] [Abstract][Full Text] [Related]
8. Cancer anorexia/cachexia.
Goldberg RM; Loprinzi CL
Cancer Treat Res; 1999; 100():31-41. PubMed ID: 10645495
[No Abstract] [Full Text] [Related]
9. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
10. Anorexia and cachexia in advanced cancer patients.
Vigano A; Watanabe S; Bruera E
Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
[TBL] [Abstract][Full Text] [Related]
11. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
12. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
Cabeza C; Corsi O; Pérez-Cruz P
Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
[TBL] [Abstract][Full Text] [Related]
13. Update on anorexia and cachexia.
Strasser F; Bruera ED
Hematol Oncol Clin North Am; 2002 Jun; 16(3):589-617. PubMed ID: 12170570
[TBL] [Abstract][Full Text] [Related]
14. What is next after anamorelin?
Garcia JM
Curr Opin Support Palliat Care; 2017 Dec; 11(4):266-271. PubMed ID: 28957883
[TBL] [Abstract][Full Text] [Related]
15. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
16. Modern management of the cancer anorexia-cachexia syndrome.
Nelson KA
Curr Oncol Rep; 2000 Jul; 2(4):362-8. PubMed ID: 11122866
[TBL] [Abstract][Full Text] [Related]
17. Appetite stimulants for patients with cancer: current evidence for clinical practice.
Turcott JG; Zatarain-Barrón ZL; Cárdenas Fernández D; Castañares Bolaños DT; Arrieta O
Nutr Rev; 2022 Mar; 80(4):857-873. PubMed ID: 34389868
[TBL] [Abstract][Full Text] [Related]
18. Management of cancer anorexia/cachexia.
Loprinzi CL
Support Care Cancer; 1995 Mar; 3(2):120-2. PubMed ID: 7773579
[TBL] [Abstract][Full Text] [Related]
19. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
20. Assessment and nonpharmacological management for patients with cancer anorexia-cachexia syndrome: a best practice implementation project.
Zhang L; Zhou C; Wu Y; Du D; He L; He L; Xie G; Wang L; Chen P
JBI Evid Implement; 2022 Dec; 20(4):334-343. PubMed ID: 35275849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
